Gastric epithelial cell modality and proton pump inhibitor

Journal of Clinical Biochemistry and Nutrition

Volumn 42, Issue 3, 2008, Pages 191-196

  Masaoka, Tatsuhiro ^a,b   Suzuki, Hidekazu ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Life Extension Research Institute   (Japan)

Author keywords

Chief cell; Gastric fundic gland; Ghrelin; Pariental cell; Proton pump inhibitor

Indexed keywords

CIMETIDINE; FAMOTIDINE; GHRELIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP; PROTON PUMP INHIBITOR;

A LIKE CELL; ATROPHIC GASTRITIS; CELL ENLARGEMENT; DISEASE MODEL; DRUG EFFECT; DRUG SAFETY; ENTEROCHROMAFFIN LIKE CELL; EPITHELIUM CELL; HUMAN; LONG TERM CARE; NONHUMAN; PEPTIC ULCER; REFLUX ESOPHAGITIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; STOMACH CARCINOID; STOMACH CHIEF CELL; STOMACH EPITHELIUM; STOMACH FUNDUS; STOMACH MUCOSA; STOMACH PARIETAL CELL; STOMACH POLYP;

ANIMALIA;

EID: 46349091345     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.2008028     Document Type: Review

References (45)

1. Shull, G.E. and Lingrel, J.B.: Molecular cloning of the rat stomach (H++ K+)-ATPase. J. Biol. Chem., 261, 16788-16791, 1986.
2. Yeo, M., Kim, K.D., Chung, S.I., Moon, S.B., Song, S.K., and Hahm, B.K.: The Novel Acid Pump Antagonists for Anti-secretory Actions with Their Peculiar Applications Beyond Acid Suppression. J. Clin. Biochem. Nutr., 38, 1-8, 2006.
3. Besancon, M., Simon, A., Sachs, G., and Shin, J.M.: Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J. Biol. Chem., 272, 22438-22446, 1997.
4. Nakamura, M., Matsui, H., Serizawa, H., and Tsuchimoto, K.: Lansoprazole Novel Effector Sites Revealed by Auto-radiography: Relation to Helicobacter pylori, Colon, Esophagus and Others. J. Clin. Biochem. Nutr., 41, 154-159, 2007.
5. Mears, J.M. and Kaplan, B.: Proton pump inhibitors: new drugs and indications. Am. Fam. Physician., 53, 285-292, 1996.
6. Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells. Anat. Rec, 236, 280-296, 1993.
7. Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat. Rec, 236, 297-313, 1993.
8. Karam, S.M.: Dynamics of epithelial cells in the corpus of the mouse stomach. IV. Bidirectional migration of parietal cells ending in their gradual degeneration and loss. Anat. Rec, 236, 314-332, 1993.
9. Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero-endocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat. Rec, 236, 333-340, 1993.
10. Forte, J.G., Forte, T.M., Black, J.A., Okamoto, C., and Wolosin, J.M.: Correlation of parietal cell structure and function. J. Clin. Gastroenterol., 5 Suppl 1, 17-27, 1983.
11. Karasawa, H., Tani, N., and Miwa, T.: The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol. Jpn., 23, 1-8, 1988.
12. Spicer, Z., Miller, M.L., Andringa, A., Riddle, T.M., Duffy, J.J., Doetschman, T., and Shull, G.E.: Stomachs of mice lacking the gastric H,K-ATPase alpha-subunit have achlo-rhydria, abnormal parietal cells, and ciliated metaplasia. J. Biol. Chem., 275, 21555-21565, 2000.
13. Grahammer, F., Herling, A.W., Lang, H.J., Schmitt-Graff, A., Wittekindt, O.H., Nitschke, R., Bleich, M., Barhanin, J., and Warth, R.: The cardiac K+ channel KCNQ1 is essential for gastric acid secretion. Gastroenterology, 120, 1363-1371, 2001.
14. Heitzmann, D., Grahammer, F., von Hahn, T., Schmitt-Graff, A., Romeo, E., Nitschke, R., Gerlach, U., Lang, H.J., Verrey, F., Barhanin, J., and Warth, R.: Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells. J. Physiol, 561, 547-557, 2004.
15. Elso, CM., Lu, X., Culiat, C.T., Rutledge, J.C., Cacheiro, N.L., Generoso, W.M., and Stubbs, L.J.: Heightened susceptibility to chronic gastritis, hyperplasia and metaplasia in Kcnql mutant mice. Hum. Mol. Genet, 13, 2813-2821, 2004.
16. Roepke, T.K., Anantharam, A., Kirchhoff, P., Busque, S.M., Young, J.B., Geibel, J.P., Lerner, D.J., and Abbott, GW.: The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J. Biol. Chem., 281, 23740-23747, 2006.
17. Franic, TV., Judd, L.M., Robinson, D., Barrett, S.P., Scarff, K.L., Gleeson, P.A., Samuelson, L.C., and Van Driel, I.R.: Regulation of gastric epithelial cell development revealed in H(+)/K(+)-ATPase beta-subunit- and gastrin-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol, 281, G1502-1511, 2001.
18. Helander, H.F., Simonsson, M., Sundler, F., Rutgersson, K., Helander, K.G., and Eriksson, S.: Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists. Virchows Arch A Pathol. Anat. Histopathol, 417, 305-309, 1990.
19. Driman, D.K., Wright, C., Tougas, G., and Riddell, R.H.: Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig. Dis. Sci., 41, 2039-2047, 1996.
20. van den Brink, G.R., Hardwick, J.C., Tytgat, G.N., Brink, M.A., Ten Kate, F.J., Van Deventer, S.J., and Peppelenbosch, M.P.: Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology, 121, 317-328, 2001.
21. Suzuki, H., Minegishi, Y., Nomoto, Y., Ota, T., Masaoka, T., van den Brink, G.R., and Hibi, T.: Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils. J. Pathol., 206, 186-197, 2005.
22. Nishizawa, T., Suzuki, H., Masaoka, T., Minegishi, Y., Iwasahi, E., and Hibi, T.: Helicobacter pylori eradication restored sonic hedgehog expression in the stomach. Hepato-gastroenterology, 54, 697-700, 2007.
23. Minegishi, Y., Suzuki, H., Arakawa, M., Fukushima, Y., Masaoka, T., Ishikawa, T., Wright, N.A., and Hibi, T.: Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions. J. Pathol., 213, 161-169, 2007.
24. Kakei, N., Ichinose, M., Tatematsu, M., Shimizu, M., Oka, M., Yahagi, N., Matsushima, M., Kurokawa, K., Yonezawa, S., Furihata, C., Shiokawa, K., Kageyama, T., Miki, K., and Fukamachi, H.: Effects of long-term omeprazole treatment on adult rat gastric mucosa - enhancement of the epithelial cell proliferation and suppression of its differentiation. Biochem. Biophys. Res. Commun., 214, 861-868, 1995.
25. Sachs, G., Zeng, N., and Prinz, C: Physiology of isolated gastric endocrine cells. Annu. Rev. Physiol., 59, 243-256, 1997.
26. Simonsson, M., Eriksson, S., Hakanson, R., Lind, T., Lonroth, H., Lundell, L., O'Connor, D.T., and Sundler, F.: Endocrine cells in the human oxyntic mucosa. A histo-chemical study. Scand. J. Gastroenterol., 23, 1089-1099, 1988.
27. Bottcher, G., Hakanson, R., Nilsson, G., Seensalu, R., and Sundler, F.: Effects of long-term hypergastrinaemia on the ultrastructure of enterochromaffin-like cells in the stomach of the rat, hamster and guinea pig. Cell Tissue Res., 256, 247-257, 1989.
28. Lamberts, R., Creutzfeldt, W., Struber, H.G., Brunner, G., and Solcia, E.: Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastro-enterology, 104, 1356-1370, 1993.
29. Eissele, R., Brunner, G., Simon, B., Solcia, E., and Arnold, R.: Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyper-plasia. Gastroenterology, 112, 707-717, 1997.
30. Suzuki, H., Masaoka, T., Minegishi, Y., Motosugi, Y., Miura, S., and Ishii, H.: Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44/p42 mitogen-activated protein kinase. Wound Repair Regen., 12, 93-99, 2004.
31. Havu, N.: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion, 35 Suppl 1, 42-55, 1986.
32. Maton, P.N., Lack, E.E., Collen, M.J., Cornelius, M.J., David, E., Gardner, J.D., and Jensen, R.T.: The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. Gastroenterology, 99, 943-950, 1990.
33. Jensen, R.T., Metz, D.C., Koviack, P.D., and Feigenbaum, K.M.: Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome. Aliment Pharmacol. Then, 7 Suppl 1, 41-50, discussion 61-66, 1993.
34. Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M.S., Suganuma, T., Matsukura, S., Kangawa, K., and Nakazato, M.: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255-4261, 2000.
35. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656-660, 1999.
36. Mori, M., Suzuki, H., Masaoka, T., Imaeda, H., Nomoto, Y., Hosoda, H., Nishizawa, T., Kangawa, K., and Hibi, T.: Intravenous ghrelin administration enhances gastric acid secretion - evaluation using wireless pH capsule. Aliment Pharmacol. Then, 24 Suppl 4, 96-103, 2006.
37. Cui, G.L., Syversen, U., Zhao, CM., Chen, D., and Waldum, H.L.: Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. Scand. J. Gastroenterol, 36, 1011-1015, 2001.
38. Suzuki, H., Masaoka, T., Hosoda, H., Ota, T., Minegishi, Y., Nomura, S., Kangawa, K., and Ishii, H.: Helicobacter pylori infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut, 187-194, 2004.
39. Suzuki, H., Masaoka, T., Hosoda, H., Nomura, S., Ohara, T., Kangawa, K., Ishii, H., and Hibi, T.: Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio - a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterol., 1249-1254, 2004.
40. Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., Havu, N., Festen, H.P., Liedman, B., Lamers, C.B., Jansen, J.B., Dalenback, J., Snel, P., Nelis, G.F., and Meuwissen, S.G.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med, 334, 1018-1022, 1996.
41. Lundell, L., Miettinen, P., Myrvold, H.E., Pedersen, S.A., Thor, K., Andersson, A., Hattlebakk, J., Havu, N., Janatuinen, E., Levander, K., Liedman, B., and Nystrom, P.: Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology, 117, 319-326, 1999.
42. Kuipers, E.J., Nelis, G.F., Klinkenberg-Knol, E.C., Snel, P., Goldfain, D., Kolkman, J.J., Festen, H.P., Dent, J., Zeitoun, P., Havu, N., Lamm, M., and Walan, A.: Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut, 53, 12-20, 2004.
43. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Mashiba, H., Sasaki, N., and Taniyama, K.: Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. Aliment Pharmacol. Ther, 14, 1345-1352, 2000.
44. Jalving, M., Koornstra, J.J., Wesseling, J., Boezen, H.M., S, D.E.J., and Kleibeuker, J.H.: Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol. Ther, 24, 1341-1348, 2006.
45. Vieth, M. and Stolte, M.: Fundic gland polyps are not induced by proton pump inhibitor therapy. Am. J. Clin. Pathol, 116, 716-720, 2001.